Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of PROSC mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of PROSC mRNA | affects expression | 21346803
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PROSC mRNA | decreases expression | 20018196
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of PROSC mRNA | increases expression | 19150397
|
D008942 |
Mitoxantrone |
PROSC protein affects the susceptibility to Mitoxantrone | affects response to substance | 16217747
|
C037219 |
quinoline |
quinoline analog results in increased expression of PROSC protein | increases expression | 18645022
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of PROSC mRNA | increases expression | 16054129
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.87 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.25 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.32 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.42 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.78 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.93 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.24 | 16873071 16166294 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.05 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.68 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
6.98 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
6.98 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
quinoline |
6.98 | 598648 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
6.98 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.36 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.26 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.35 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.35 | 20889678 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.05 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.68 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.78 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.12 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 9211117 9125849 17551590 8800419 16925845 9664655 10589399 14991402 9142499 9224671 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
12.32 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
12.32 | 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.11 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.11 | 18551238 21346803 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.99 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.30 | 16569247 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.13 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.81 | 9664655 16938888 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.93 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.19 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.38 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.68 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.04 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Mitoxantrone |
4.36 | 16019553 |
MESH:D006390 |
Hemangioendothelioma |
|
quinoline |
6.42 | 598648 |
MESH:D006394 |
Hemangiosarcoma |
|
quinoline |
5.32 | 598648 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.46 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.99 | 16778211 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.18 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.23 | 17551590 15992940 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.27 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.27 | 16705839 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.90 | 17143497 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Mitoxantrone |
3.90 | 18172266 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.02 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.12 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.34 | 16140955 19075265 16766008 17712046 16935935 17506722 16331271 17361223 15748426 16823087 19642359 9834237 19035177 16891316 19225113 17294898 17107899 12679006 17339181 16788101 19029980 17649720 17301526 17368321 17217047 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.53 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.24 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.72 | 6135515 2876784 2876786 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.88 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.84 | 16940565 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.24 | 17596541 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.94 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.94 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
quinoline |
4.15 | 598648 |
MESH:D009369 |
Neoplasms |
|
Mitoxantrone |
5.91 | 16640825 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.91 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.16 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.24 | 9142499 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.92 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.92 | 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.42 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.16 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.55 | 15976015 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.95 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.26 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.45 | 16116481 16283617 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.56 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.56 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.73 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.26 | 16026305 17045167 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.09 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.41 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.36 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.36 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.58 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.58 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.98 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.13 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.44 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.25 | 16287080 |